Elisabetta Tedone
Overview
Explore the profile of Elisabetta Tedone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riva C, Minetto P, Chies M, Vernarecci C, Colombo N, Rosellini S, et al.
Hematol Oncol
. 2024 Dec;
43(1):e70005.
PMID: 39635952
Secondary acute myeloid leukemia (s-AML) is associated with inferior outcomes with conventional chemotherapy, and fludarabine combinations (FLAG-Ida) have been tested to improve results. More recently, CPX-351 resulted superior to conventional...
2.
Gambella M, Carlomagno S, Mangerini R, Colombo N, Parodi A, Ghiggi C, et al.
EJHaem
. 2024 Apr;
5(2):360-368.
PMID: 38633118
CAR CD4 T cell lymphopenia is an emerging issue following CAR-T cell therapy. We analyzed the determinants of CD4 T cell recovery and a possible association with survival in 31...
3.
Guolo F, Minetto P, Pesce S, Ballerini F, Clavio M, Cea M, et al.
Front Immunol
. 2021 Nov;
12:753890.
PMID: 34804039
Immune checkpoint inhibitors (CI) have demonstrated clinical activity in Hodgkin Lymphoma (HL) patients relapsing after autologous stem cell transplantation (ASCT), although only 20% complete response (CR) rate was observed. The...
4.
Guolo F, di Grazia C, Minetto P, Raiola A, Clavio M, Miglino M, et al.
Eur J Haematol
. 2021 Jul;
107(5):573-582.
PMID: 34297437
We studied pretransplant minimal residual disease (MRD) in 224 patients (median age 44 years; range 17-65) with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplant (HSCT) in complete remission....
5.
Dentone C, Vena A, Loconte M, Grillo F, Brunetti I, Barisione E, et al.
BMC Infect Dis
. 2021 Apr;
21(1):353.
PMID: 33858331
Background: The primary objective of the study is to describe the cellular characteristics of bronchoalveolar lavage fluid (BALF) of COVID-19 patients requiring invasive mechanical ventilation; the secondary outcome is to...
6.
Guolo F, Minetto P, Clavio M, Marcolin R, Miglino M, Passannante M, et al.
Leuk Lymphoma
. 2020 Mar;
61(7):1695-1701.
PMID: 32186422
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a poor prognosis myeloid malignancy characterized by an atypical phenotype (CD123+, CD56+, and CD4+). We reported that BPDCN-like phenotype (CD123+ and either CD56+...
7.
Marcolin R, Guolo F, Minetto P, Clavio M, Manconi L, Ballerini F, et al.
Leuk Res
. 2019 Sep;
86:106223.
PMID: 31557597
Acute myeloid leukemia with biallelic mutation of CEBPA (CEBPA-dm AML) is a distinct good prognosis entity recognized by WHO 2016 classification. However, testing for CEBPA mutation is challenging, due to...
8.
Cannizzo E, Raia M, De Propris M, Triolo A, Scarpati B, Marfia A, et al.
Ann Hematol
. 2019 Mar;
98(5):1083-1093.
PMID: 30868306
In this study, we aimed at disclosing the main features of paroxysmal nocturnal hemoglobinuria (PNH) clones, their association with presentation syndromes, and their changes during follow-up. A large-scale, cooperative collection...
9.
Marini C, Bruno S, Fiz F, Campi C, Piva R, Cutrona G, et al.
Sci Rep
. 2017 Oct;
7(1):14159.
PMID: 29074954
Skeletal erosion has been found to represent an independent prognostic indicator in patients with advanced stages of chronic lymphocytic leukaemia (CLL). Whether this phenomenon also occurs in early CLL phases...
10.
Raiola A, Risitano A, Sacchi N, Giannoni L, Signori A, Aquino S, et al.
Biol Blood Marrow Transplant
. 2017 Oct;
24(1):119-126.
PMID: 29024804
We studied the impact of HLA mismatching on the outcome of 318 consecutive patients who received an unmanipulated haploidentical bone marrow transplant, followed by post-transplant cyclophosphamide (PTCy). The number of...